In the fight against Mexican criminal cartels, social network analysis can predict and map out their alliances and subgroups — using algorithms to predict new connections. In this commentary, Nonresident Scholar in Drug Policy and Mexico Studies Nathan P. Jones and his co-authors outline their recent work in the field.
Nathan P. Jones, Oscar Contreras Velasco, John P. Sullivan, Chris Callaghan, Irina Chindea, Daniel Weisz ArgomedoOctober 18, 2023
Considering the dangers of advanced AI and AI-enhanced social media, there is an urgent need to design neuroscience-based policies to support citizens in building a system of digital self-defense. Enter the “Neuroshield.”
Last month, China released its 14th Five-Year Plan (2021-2025) for the energy sector. While clean and low-carbon may be the keywords on paper, in reality, Beijing will continue rely on coal to power its economy and energy transitions, writes the author. Read the post on the Baker Institute Blog.
The first step to reducing methane, Agerton and Gilbert argue, is to directly measure it. Their new Forbes post explains why inventory-based incentives that merely estimate emissions must give way to direct methane monitoring.
An overview of the ABA's Cannabis Law & Policy Committee, which is composed of attorneys across North America who have various mainstream practices and who seek to be stewards of historic changes in the pioneering field of marijuana law.
Products containing hemp extracts high in CBD are gaining mainstream popularity, acceptance and federal legality. In this article, Lisa Pittman, nonresident fellow in drug policy, focuses on litigation issues particular to hemp.
According to the authors, as a leading agricultural state, Texas is poised to become the new leader in hemp production, whether for medicinal or industrial purposes.
According to the authors, developments in cannabis law, arbitration clause interpretation and the economic loss doctrine show that numerous facets of business litigation are changing rapidly.
